Literature DB >> 3137808

Immunohistochemical studies on intrahepatic lymphocyte infiltrates in chronic type B hepatitis, with special emphasis on the activation status of the lymphocytes.

P M Yang1, I J Su, M Y Lai, G T Huang, H C Hsu, D S Chen, J L Sung.   

Abstract

To study the immunopathogenesis of chronic type B hepatitis, we used a panel of monoclonal antibodies to characterize the intrahepatic mononuclear cell infiltrates in 39 patients with various forms of chronic hepatitis induced by hepatitis B virus (HBV) and, for comparison, in 10 with non-A, non-B (NANB)-induced chronic hepatitis. In portal areas, the OKT4:OKT8 ratio reversed because of the relative increase of OKT8+ cells. The mean intraportal T4:T8 ratio was significantly lower in HBV-associated chronic active hepatitis (CAH) than in chronic persistent hepatitis induced by HBV or NANB viruses. OKT8+ cells were predominant in the infiltrates of periportal areas (piecemeal necrosis) and lobules. As to the activation status of the infiltrates, T10 was found much more frequently on mononuclear infiltrates of piecemeal necrosis and peripheral portion of portal areas in CAH cases, regardless of viral etiology, and its existence was correlated with the severity of CAH. Natural killer cells, killer cells, and B-cells played little role in the pathogenesis of hepatocytolysis. We conclude that T-cell cytotoxicity is the main mechanism of hepatocytolysis, either in lobules or in periportal regions, and that T10 antigen defines a group of cells which may play an important role associated with the formation of piecemeal necrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137808

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Immunoelectron microscopic observations on Leu-7 positive cells in virus-related chronic liver diseases.

Authors:  H Himeno; H Enzan; T Saibara; S Onishi; Y Yamamoto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.

Authors:  H J Flink; D Sprengers; B E Hansen; M van Zonneveld; R A de Man; S W Schalm; H L A Janssen
Journal:  Gut       Date:  2005-05-29       Impact factor: 23.059

3.  Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.

Authors:  Cyriac Abby Philips; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.

Authors:  R Wejstål; G Norkrans; O Weiland; R Schvarcz; D Fuchs; H Wachter; A Fryden; H Glaumann
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice.

Authors:  S D Olver; P Price; G R Shellam
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

6.  Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B.

Authors:  B N Pham; J F Mosnier; F Walker; C Njapoum; F Bougy; C Degott; S Erlinger; J H Cohen; F Degos
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 7.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

8.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Authors:  M K Maini; C Boni; C K Lee; J R Larrubia; S Reignat; G S Ogg; A S King; J Herberg; R Gilson; A Alisa; R Williams; D Vergani; N V Naoumov; C Ferrari; A Bertoletti
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

Review 9.  Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.

Authors:  Wei-Lun Tsai; Wei-Chi Sun; Jin-Shiung Cheng
Journal:  Int J Mol Sci       Date:  2015-11-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.